Neurodegenerative diseases

The case of the sticky protein

Proteins are like a body’s in-house Lego set. These large, complex molecules are made up of building blocks called amino acids. Most of the time, proteins fold correctly, but sometimes they can misfold. This misfolding causes the proteins to get sticky, and that can promote clumping, or aggregation, which is the hallmark of several neurodegenerative diseases such as ALS, Alzheimer’s and Parkinson’s.

Ashutosh Tiwari and his doctoral student Nethaniah Dorh work on misfolded...
Ashutosh Tiwari and his doctoral student Nethaniah Dorh work on misfolded proteins. They collaborated with synthetic chemists and physicists to better understand a BODIPY-based probe to test protein stickiness, a precursor to some neurodegenerative diseases.
Source: Michigan Tech/Sarah Bird

The protein’s stickiness is a result of surface hydrophobic interactions that are important for many biological functions. The problem is that researchers don’t have good tools to measure this stickiness with high sensitivity.

Now, an interdisciplinary team at Michigan Technological University has assembled new tools to solve the case of the sticky protein. Their work on improving hydrophobicity detection using BODIPY-based probes will be published in Scientific Reports.

Using fluorescent probes, the team measured hydrophobicity in three proteins: Bovine Serum Albumin (BSA), apomyoglobin and myoglobin. Compared to a commonly used commercial sensor (ANS), these new BODIPY-based hydrophobic sensors showed much stronger signal strengths, with up to a 60-fold increase in BSA.

“This is like going from having one 40-watt light bulb and then having 60 of them in the same room, just imagine the difference in illumination,” says Ashutosh Tiwari, an associate professor of chemistry at Michigan Tech and the corresponding author for the study.


Source: Michigan Technological University

07.01.2016

More on the subject:

Related articles

Photo

News • Polygenic risk assessment

Sleep study for early detection of Alzheimer's risk

New research suggests that subtle markers during sleep – such as nocturnal micro-awakenings – may yield early clues to a greater genetic risk of developing Alzheimer’s disease.

Photo

News • Biomarker panel

Seven proteins could lead to better blood tests for Alzheimer’s

More biomarkers for better insights on Alzheimer's disease: a new study explores how a panel of seven proteins could help predict disease progression and inform more accurate treatment choices.

Photo

News • Neuroimaging

Alzheimer’s: MRI metric identifies early white matter damage

A diffusion MRI metric can detect changes in white matter tracts not visible on conventional MRI – this could help identify early abnormalities in the brain associated with Alzheimer’s disease.

Subscribe to Newsletter